Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBR0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,930
Award facts
- Contract value 100% obligated
- $51,929.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $51,929.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. This firm fixed-price delivery order, issued on December 15, 2025, is scheduled for ultimate completion by January 7, 2026, with no set-aside designation applied. DMS Pharmaceutical Group will perform the work at its Park Ridge, Illinois facility. This delivery order is issued under the company's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded in November 2025 with a $499.9 billion ceiling and extends through December 31, 2036.
The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors as critical suppliers for Department of Defense pharmaceutical and medical consumable needs. DMS Pharmaceutical Group's inclusion as a prime vendor contractor reflects its established capability to supply diverse pharmaceutical products, including specialty medications and biologics, to military healthcare facilities worldwide. As the sole prime contractor on this delivery order with no identified subcontractors, DMS Pharmaceutical Group will directly fulfill the DLA's Botox requirements, leveraging its demonstrated performance across numerous prior delivery orders spanning various therapeutic categories and product lines essential to federal military medical operations.
Quick answers
Who was awarded contract SPE2DR26FFBR0?
SPE2DR26FFBR0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FFBR0 worth?
The government has obligated $51,930 on SPE2DR26FFBR0.
Is contract SPE2DR26FFBR0 an order under another contract?
Yes. SPE2DR26FFBR0 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBR0 competed?
The extent of competition for SPE2DR26FFBR0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award